Opposing roles for IL‐13 and IL‐13 receptor α2 in health and disease
Authors:
- 11 November 2004
- journal article
- review article
- Published by Wiley in Immunological Reviews
- Vol. 202 (1) , 191-202
Abstract
Summary: Interleukin (IL)‐13 is a key inducer of several type‐2 cytokine‐dependent pathologies. It regulates inflammation, mucus production, tissue remodeling, and fibrosis. Consequently, it has become an important therapeutic target for a number of debilitating illnesses, including asthma, idiopathic pulmonary fibrosis, ulcerative colitis, as well as several other diseases in which IL‐13 is believed to be overproduced. In the murine model of schistosomiasis, IL‐13 has emerged as a central mediator of chronic infection‐induced liver pathology. Although IL‐4, IL‐5, IL‐10, and IL‐13 each regulate distinct aspects of the granulomatous inflammatory response, IL‐13 was identified as the primary mediator of liver fibrosis. Thus, elucidating the mechanisms that regulate the production and function of IL‐13 has become an intensive area of research. IL‐13 signaling is mediated by the type‐2 IL‐4 receptor, which consists of the IL‐4Rα and IL‐13Rα1 chains. However, another IL‐13‐binding chain, IL‐13Rα2, appears to strongly inhibit the activity of IL‐13. Animals deficient in IL‐13Rα2 fail to downmodulate granuloma formation in the chronic phase of infection. They also develop severe IL‐13‐dependent fibrosis and portal hypertension and quickly succumb to the infection. Here, we summarize findings from the schistosomiasis model, which illustrate opposing activities for IL‐13 and IL‐13Rα2 in health and disease.Keywords
This publication has 70 references indexed in Scilit:
- Transforming Growth Factor (TGF)-β1–producing Regulatory T Cells Induce Smad-mediated Interleukin 10 Secretion That Facilitates Coordinated Immunoregulatory Activity and Amelioration of TGF-β1–mediated FibrosisJournal of Experimental Medicine, 2003
- Interleukin-4 and Interleukin-13 Signaling Connections MapsScience, 2003
- Enhanced Interleukin (IL)-13 Responses in Mice Lacking IL-13 Receptor α 2Journal of Experimental Medicine, 2003
- Regulation and Function of the Interleukin 13 Receptor α 2 During a T Helper Cell Type 2–dominant Immune ResponseJournal of Experimental Medicine, 2003
- Decoy Receptors in the Regulation of T Helper Cell Type 2 ResponsesJournal of Experimental Medicine, 2003
- The immunobiology of schistosomiasisNature Reviews Immunology, 2002
- Disease fingerprinting with cDNA microarrays reveals distinct gene expression profiles in lethal type‐1 and type‐2 cytokine‐mediated inflammatory reactionsThe FASEB Journal, 2001
- Expression of Interleukin 13 Receptor in Glioma and Renal Cell Carcinoma: IL13Rα2 as a Decoy Receptor for IL13Laboratory Investigation, 2001
- Receptors and cytokines involved in allergic TH2 cell responsesJournal of Allergy and Clinical Immunology, 1999
- Acquisition of Lymphokine-Producing Phenotype By CD4+ T CellsAnnual Review of Immunology, 1994